1. Prognostic impact of anticancer immune responses: an introduction

   • Franck Pagés
   • Guido Kroemer

   Review 28 May 2011 Pages: 317 - 319

2. HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition

   • Michael Campoli
   • Soldano Ferrone

   Review 28 April 2011 Pages: 321 - 334

   

3. The prognostic impact of anti-cancer immune response: a novel classification of cancer patients

   • Gabriela Bindea
   • Bernhard Mlecnik
   • Jérôme Galon

   Review Open access 05 April 2011 Pages: 335 - 340

   

4. Anti-cancer immune response mechanisms in neoadjuvant and targeted therapy

   • Carsten Denkert
   • Silvia Darb-Esfahani
   • Korinna Jöhrens

   Review 17 April 2011 Pages: 341 - 351

   

5. Contribution of the immune system to the chemotherapeutic response

   • Alison M. McDonnell
   • Anna K. Nowak
   • Richard A. Lake

   Review 28 January 2011 Pages: 353 - 367

   

6. Immunomodulatory effects of cyclophosphamide and implementations for vaccine design

   • Antonella Sistigu
   • Sophie Viaud
   • Laurence Zitvogel

   Review 25 May 2011 Pages: 369 - 383

   

7. Prognostic significance of autoimmunity during treatment of melanoma with interferon

   • Michal T. Krauze
   • Ahmad Tarhini
   • John M. Kirkwood

   Review 31 January 2011 Pages: 385 - 391